Stéphane Bancel, Moderna CEO (Hollie Adams/Bloomberg via Getty Images)

FDA ap­proves Mod­er­na's RSV vac­cine, mark­ing its sec­ond com­mer­cial prod­uct

Mod­er­na on Fri­day se­cured a long-await­ed but ex­pect­ed ap­proval for its RSV vac­cine, giv­ing the biotech its first FDA ap­proval for a non-Covid-19 prod­uct and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.